Does ALEMTUZUMAB Cause Urinary tract infection? 746 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 746 reports of Urinary tract infection have been filed in association with ALEMTUZUMAB (Campath). This represents 5.3% of all adverse event reports for ALEMTUZUMAB.
746
Reports of Urinary tract infection with ALEMTUZUMAB
5.3%
of all ALEMTUZUMAB reports
36
Deaths
420
Hospitalizations
How Dangerous Is Urinary tract infection From ALEMTUZUMAB?
Of the 746 reports, 36 (4.8%) resulted in death, 420 (56.3%) required hospitalization, and 35 (4.7%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 746 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which ALEMTUZUMAB Alternatives Have Lower Urinary tract infection Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET